Stroke risk stratification in acute dizziness presentations
A prospective imaging-based study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 16, 2014
- Accepted in final form June 29, 2015
- First Published October 28, 2015.
Article Versions
- Previous version (October 28, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Kevin A. Kerber, MD,
- William J. Meurer, MD,
- Devin L. Brown, MD,
- James F. Burke, MD,
- Timothy P. Hofer, MD,
- Alexander Tsodikov, PhD,
- Ellen G. Hoeffner, MD,
- A.M. Fendrick, MD,
- Eric E. Adelman, MD and
- Lewis B. Morgenstern, MD
- Kevin A. Kerber, MD,
NONE
NONE
(1) Elsevier Inc, author honoraria (2) American Academy of Neurology, travel funding
NONE
NONE
(1) Clinical Neurophysiology of the Vestibular System, 4th edition, Oxford University Press, 2011
NONE
(1) American Academy of Neurology (2) University of California San Francisco (including work on a project funded by AstraZeneca) (3) Best Doctors, Inc
NONE
(1) NIH, loan repayment award. (2) American Academy of Neurology, speaker honoraria (3) University of Southern California, speaker honoraria
NONE
NONE
(1) NIH/NIDCD R01DC012760, principal investigator, 2013- 2018 (2) AHRQ R18HS022258, principal investigator, 2014-2019 (3) AHRQ R18 HS017690, principal investigator, 2009-2013 (4) NIH U01DC013778-01A1, site investigator, 2014-2019
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Phil Pearsons, MD, JD., review of legal records, 2013 (2) National Medical Consultants, review of legal records, 2014
- William J. Meurer, MD,
NONE
NONE
NONE
Society of Academic Emergency Medicine, Compensated Methodology Statistics Reviewer, 2009-2014
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Agency for Healthcare Quality and Research #R18HS017690, CO-Investigator 2009-2013 (2) National Institute of Neurological Disorders and Stroke / Food and Drug Administration #U01NS073476, Co- Investigator 2012-present (3) National Institute of Neurological Disorders and Stroke U01NS056975, Co-Investigator 2010-2013 (4) National Institute of Deafness and Communication Disorders, R01 DC012760, Principal Investigator (Multiple) 2013-present (5) Agency for Healthcare Quality and Research, R18HS022258, Co- Investigator, 2014-present (6) National Institute of Deafness and Communication Disorders, U01 DC013778, Site CoInvestigator 2014-present (7) National Institute of Neurological Disorders and Stroke R25 NS088248, Principal-Investigator 2014-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Devin L. Brown, MD,
Steering Committee Member, Northern Manhattan Initiative for Minority involvement in Clinical Trials (NIMICT) (U24MD006961); StrokeNet Trial Recruitment and Retention for Under-represented Minorities and Ethnicities Advisory Committee (NINDS)
NONE
Wayne State University, honorarium for talk.
(1) Neurology, editorial board member, 2008-present (2) Stroke, editorial board member, 2011-June 2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
CVR Global, Inc, 12/12/08 ? 06/30/10, research grant.
AHRQ, R18 HS017690, Co-I, 12/1/09 ? 11/30/13 NINDS, R01 NS062675, PI, 06/15/09 ? 05/31/14 NHLBI, R01 HL098065, PI, 06/01/10 ? 05/31/14 NINDS, R01 NS070941, PI, 05/01/11 - 04/30/16 NIH, R01 DC012760, Co-I, 08/1/13 - 07/31/18 NINDS, U10NS086526, PI, 09/01/13 - 07/01/18 NHLBI, R01HL123379, PI, 4/17/15 - 03/31/19
NONE
(1) Blue Cross Blue Shield of Michigan Foundation, (2) Michigan Department of Community Health
NONE
NONE
NONE
NONE
NONE
NONE
- James F. Burke, MD,
NONE
NONE
American Academy of Neurology, Continuum Article
NONE
NONE
NONE
NONE
NONE
NONE
Dr. Burke has received compensation from Astra Zeneca for his role as an adjudicator in the SOCRATES trial.
NONE
NONE
Dr. Burke is funded by NIH K08 NS082597 and R01 MD008879.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Dr. Burke has reviewed case materials in a medical malpractice defense case.
- Timothy P. Hofer, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Project Number: P01CA163233-01A1 Source: NIH P01 (S Katz) Title of Project: The Challenge of Individualizing Treatments for Patients with Breast Cancer Dates of Project: 9/1/12-8/31/17 Project Number: R01-HS-018334-05 (McMahon) Source: AHRQ Title of Project: Models of hospital-acquired conditions and readmission: defining at-risk patients Dates of Project: 9/1/13-8/31/16 Project Number: P30DK092926-01 (W Herman) Source: NIH/NIDDK Title of Project: Michigan Center for Diabetes Translational Research (P30) Dates of Project: 9/6/11-6/30/16 Project Number: 1-R01-HS-022305-01-A1 (Manojlovich) Source: AHRQ Title of Project: The Effect of Health Information Technology on Healthcare Provider Communication Dates of Project: 09/30/2014-09/29/2018 Project Number: K08 HS19767-01 (J Meddings) Source: AHRQ Title of Project: Targeting Hospital-Acquired Complications: Impact on the Care of Complex Patients Dates of Project: 9/30/10-7/31/15 Project Number: DIB 98-001 (C Richardson) Source: Department of Veterans Affairs Health Services Research & Development Title of Project: Quality Enhancement Research Initiative ? Diabetes Mellitus (QUERI-DM) Dates of Project: 10/01/04-09/30/15 Project Number: CIN 13-408 (EA Kerr) Source: Department of Veterans Affairs Health Services Research & Development Title of Project: VA Center for Clinical Management Research Dates of Project: 10/01/13-09/30/18 Project Number: IIR 13-079 (Iwashyna) Source: VA Title of Project: Recovery after In-Hospital Cardiac Arrest: Late Outcomes & Utilization (ReSCU) Dates of Project: 08/01/2014-07/31/2017 Project Number: SDR 10-180 (K Langa) Source: Department of Veterans Affairs Title of Project: VA-HRS Data Linkage Project Dates of Project: 2/1/12-9/30/15 Project Number: EPID-011-11S (S Saint) Source: Department of Veterans Affairs Clinical Science Research & Development Title of Project: Predictors of Hospital-Acquired Urinary Tract-Related Bloodstream Infection in VA Project Number: IIR 12-116 (S Hawley) Source: VA Healthcare System (HSR&D) Title of Project: Optimizing Veteran-Centered Prostate Cancer Survivorship Care Dates of Project: 4/1/13-3/31/17 Project Number: IIR 11-088 (Hayward) Source: VA-ORD Title of Project: Developing and Validating a Veterans Affairs Cardiac Risk Score Dates of Project: 9/1/12-2/28/16
NONE
Source: Robert Wood Johnson Title of Project: RWJ Clinical Scholars Admin Program and Scholars 2014-2016 ID#71900 Dates of Project: 7/01/14-6/30/16
NONE
NONE
NONE
NONE
NONE
NONE
- Alexander Tsodikov, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH 1R01DC012760-01A1 (Kerber), Biostatistician
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ellen G. Hoeffner, MD,
NONE
NONE
St John Hospital, Detroit, MI, speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- A.M. Fendrick, MD,
NONE
NONE
NONE
American Journal of Managed Care
NONE
NONE
NONE
NONE
Merck and Co., Pfizer Inc.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eric E. Adelman, MD and
NONE
NONE
(1) Honorarium from the Michigan Academy of Family Physicians for CME activity.
NONE
NONE
NONE
NONE
(1) Receives consulting fees from the University of California, San Francisco for work on a project funded by AstraZeneca.
NONE
NONE
NONE
(1) Medtronic, (2) Boston Scientific
(1) NIH, U01NS062835, co-investigator, 09/2011-08/2014. (2) AHRQ, R18HS017690, co-investigator, 01/2012-03/2013.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lewis B. Morgenstern, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
AGA medical corp
NIH/NINDS [#R01 NS38916 (PI), #R01 NS050372 (Co-I),#U01 NS052510 (Co-I), #U01 NS056975 (Co-I), #U54 NS057405 (Co-I), #R01 NS062675(PI)]
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Stroke Program (K.A.K., W.J.M., D.L.B., J.F.B., E.E.A., L.B.M.) and Departments of Neurology (K.A.K., W.J.M., D.L.B., J.F.B., E.E.A., L.B.M.), Emergency Medicine (W.J.M.), Internal Medicine (T.P.H., A.M.F.), and Radiology (E.G.H.), University of Michigan Health System, Ann Arbor; and Department of Biostatistics (A.T.), University of Michigan School of Public Health, Ann Arbor.
- Correspondence to Dr. Kerber: kakerber{at}umich.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Capturing acute vertigoA vestibular event monitorAllison S. Young, Corinna Lechner, Andrew P. Bradshaw et al.Neurology, May 15, 2019 -
Article
Nucleus prepositus hypoglossi lesions produce a unique ocular motor syndromeSung-Hee Kim, David S. Zee, Sascha du Lac et al.Neurology, October 12, 2016 -
Resident and Fellow Section
Clinical Reasoning: Labyrinthine hemorrhageAn unusual etiology for peripheral vertigoSimy K. Parikh, Samuel A. Frank et al.Neurology, January 09, 2017 -
Clinical and Ethical Challenges
The evaluation of a patient with dizzinessKevin A. Kerber, Robert W. Baloh et al.Neurology: Clinical Practice, December 01, 2011